Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

A Phase 3 study of MRTX849 + Cetuximab vs. Chemotherapy in Colorectal Cancer

A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy

Disease Types: Colon

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy

For more information:

https://clinicaltrials.gov/ct2/show/NCT04793958?term=NCT04793958&draw=2&rank=1